Enavate Sciences GP, LLC - 19 Dec 2025 SCHEDULE 13D/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP)

Filing Manager: Enavate Sciences GP, LLC
Reporting Manager: Enavate Sciences GP, LLC
Security: CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share
Symbol: CAMP
Shares outstanding: 52,122,667 shares
Disclosed Ownership: 3,127,360 shares
Ownership: 6%
Form type: SCHEDULE 13D/A
Filing time: 23 Dec 2025, 17:58:09 UTC
Date of event: 19 Dec 2025
Previous filing: 15 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Enavate Sciences GP, LLC	6%	3,127,360	0	3,127,360	/s/ James P. Boylan	By James P. Boylan, Manager	0001953107
Everest Aggregator, LP	6%	3,127,360	0	3,127,360	/s/ James P. Boylan	By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager	0002040426